2m 2m 2m 2m 2m 2m 2m
KORRO BIO (KRRO)
NASDAQ
$13.17-$0.02 (-0.11%)
Price as of Aug 21, 2026 7:30 PM EDT- $194.1MMarket Cap
- -34.23%1-Year Change
- BiotechnologyIndustry
KORRO BIO (KRRO)
$13.17-$0.02 (-0.11%)
KRRO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $13.18 | ||
Change | +$0.22 (+1.70%) | ||
Open | $13.02 | ||
High | $13.56 | ||
Low | $13.02 | ||
Previous Close | $12.96 | ||
Volume | 45,706 | ||
30-Day Average Volume | 110,957 | ||
1-Week Change | -0.75% | ||
1-Month Change | 10.20% | ||
1-Year Change | -34.23% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 14.7M | ||
Total Assets | $163.4M | ||
Market Cap | $194.1M | ||
Enterprise Value | $169.2M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$18.9M | ||
Free Cash Flow | -$17.0M | ||
EBIT | -$18.8M | ||
EBITDA | -$18.4M | ||
Net Working Capital | $108.0M | ||
EPS | -$1.07 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -12 | ||
PEG | -0 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue